What is Collate?
Collate is an innovative technology firm specializing in the application of artificial intelligence to automate and simplify the intricate paperwork processes inherent in the diagnostic, medical device, and drug development sectors. The company's platform is designed to support clients throughout their entire product lifecycle, from initial concept and research phases through to successful market launch. This comprehensive approach addresses critical bottlenecks in regulatory compliance and operational efficiency, a vital need within the highly regulated life sciences industry.
How much funding has Collate raised?
Collate has raised a total of $125M across 2 funding rounds:
Angel/Seed
$30M
Unspecified
$95M
Angel/Seed (2025): $30M with participation from First Round Capital and Y Combinator
Unspecified (2026): $95M led by Redpoint Ventures
Key Investors in Collate
Redpoint Ventures
Redpoint Ventures, established in 1999, is a venture capital firm that focuses on early growth-stage companies, likely identifying Collate's potential for significant scaling.
First Round Capital
First Round Capital is an early-stage venture capital firm known for supporting startups in their foundational stages, providing expertise and resources to help companies build their products and find initial customers.
Y Combinator
Y Combinator, a prominent accelerator founded in 2005, provides seed funding and essential guidance to startups, indicating their belief in Collate's early-stage viability and disruptive potential.
What's next for Collate?
The recent major strategic investment signals a new phase of accelerated growth and market penetration for Collate. This capital infusion is expected to fuel further development of its AI-driven automation solutions, enhance its market reach, and potentially expand its service offerings to adjacent industries facing similar documentation challenges. The company is well-positioned to solidify its leadership in providing essential operational support for companies navigating the complexities of bringing life-saving and life-enhancing products to market.
See full Collate company page
